logo
  

A.P. Moller - Maersk Q2 Profit Declines; Raises FY Financial Outlook

A.P. Moller - Maersk (AMKAF.PK,AMKBF.PK) reported that its share of second quarter profit was $1.4 billion compared to $8.6 billion, prior year. Underlying profit declined to $1.3 billion from $8.5 billion, last year.

Second quarter revenue decreased to $13.0 billion from $21.6 billion, prior year. Ocean revenue decreased to $8.7 billion from $17.4 billion, driven by a decrease in freight rates and loaded volumes.

For 2023, the company now expects EBITDA underlying in a range of $9.5 billion - $11.0 billion, revised from prior guidance range of $8.0 billion - $11.0 billion. EBIT underlying is now expected in a range of $3.5 billion - $5.0 billion, revised from prior guidance range of $2.0 billion - $5.0 billion.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

In this week's video, we highlight Roche's pioneering approach for weight loss and glucose control. Meanwhile, the EMA has taken strict action on certain preterm birth drugs and Bayer has downsized its staff. In a breakthrough for cancer treatment, the FDA has approved a groundbreaking T-cell engager therapy. Amid progress, setbacks emerge as another ALS drug study has faltered, following closely on the heels of Amylyx Pharma's recent decision to withdraw its FDA-approved ALS drug, Relyvrio.

View More Videos
RELATED NEWS
Follow RTT